Form 4: Fulgent Genetics' Chief Scientific Officer Reports Tax Withholding Transaction
SEC Form 4 Filing
Hanlin Gao, Chief Scientific Officer of Fulgent Genetics, reports a transaction involving the withholding of shares to cover tax obligations related to vesting restricted stock units.
Summary
- On January 26, 2025, Hanlin Gao, the Chief Scientific Officer of Fulgent Genetics, Inc. (FLGT), reported a transaction on SEC Form 4.
- The transaction involved the withholding of 1,329 shares of common stock at a price of $17.21 per share.
- These shares were withheld to satisfy tax withholding obligations arising from the vesting of restricted stock units.
- These restricted stock units were assumed pursuant to the Agreement and Plan of Merger dated November 7, 2022.
- Following the reported transaction, Gao directly owns 918,140 shares of Fulgent Genetics common stock.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing detailing a standard tax withholding transaction. It doesn't inherently convey positive or negative sentiment.
Industry Context
This Form 4 filing is a routine disclosure related to insider transactions and is a standard practice for publicly traded companies. It provides transparency into the stock ownership of company executives.
Stakeholder Impact
- The transaction has a minimal direct impact on stakeholders, as it is a routine tax-related stock withholding.
Key Dates
| Date | Description |
|---|---|
| 2022-11-07 | Date of the Agreement and Plan of Merger by and among Fulgent Genetics, Inc., FG Merger Sub, Inc., Fulgent Pharma Holdings, Inc., and the stockholders listed therein. |
| 2022-11-09 | Date of original Form 4 filing with the U.S. Securities and Exchange Commission reporting the assumed awards. |
| 2025-01-26 | Date of the reported transaction (stock withholding for tax obligations). |
| 2025-01-28 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.